Here are relevant reports on : biotechnology-reagent-market
-
Healthcare RFID Market by Product (RFID tags, RFID readers, RFID printers), Application (tracking, monitoring), End User (Pharmaceutical and Biotechnology Companies, Hospitals) - Analysis and Global Forecasts to 2021
Radio-Frequency Identification (RFID) uses radio waves to read and capture information stored on a tag attached to an object. This tag can be read from several feet distance and does not need to be within direct line-of-sight of the reader. In healthcare industry, RFID technology can be used in supply chain applications, patient safety, and in quality assurance applications. RFID can be deployed in hospitals and clinics to improve patient flow, reduce medial errors, improve asset utilization rates, and mange inventories & implants, among others.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), Type, Technology, Application, and Region - Global Forecast to 2030
The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to USD 144.25 billion by 2030, at a CAGR of 9.4%. The report profiles key players operating in the global agriculture biotechnology market, including Bayer Crop Science, Corteva Agriscience, BASF SE, Syngenta AG, Zoetis Inc., Elanco Animal Health, Novonesis (Novozymes and Chr. Hansen), and Lallemand Plant Care, among others.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Trace Metal Analysis Market by Technology Instrument (Atomic Absorption Spectroscopy, X-Ray Fluorescence, ICP-MS), Service (FAAS, ICP-OES)), Application (Food & Beverage, Pharmaceutical & Biotechnology, Environmental Testing) - Global Forecast to 2024
The global trace metal analysis market is projected to reach USD 6.9 billion by 2024 from USD 4.4 billion in 2019, at a CAGR of 9.5%. The growth of this market is mainly driven by the stringent safety and quality regulations and new international cGMP & cGDP certification for pharmaceutical excipients, increasing spending on life science R&D, advancements in technologies, growing preference to outsource analytical requirements to third-party service providers, increasing demand from applied markets, rising opportunities in emerging countries, and the need to comply with revised USP guidelines. Prominent players in the trace metal analysis market are Thermo Fisher Scientific (US), Agilent Technologies (US), PerkinElmer, Inc. (US), Analytik Jena AG (Germany), Bruker Corporation (US), Hitachi Hi-Technologies Corporation (Japan), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), Intertek Group PLC (US), SGS S.A. (Switzerland), Bureau Veritas S.A. (France), TÜV SÜD (Germany), and LGC Ltd. (UK).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Biorefinery Market by Technology (Industrial Biotechnology, Physico-Chemical, Thermochemical), Product (Energy, Material), Type (First Generation (Corn, Vegetable Oils, Sugarcane), Second Generation, Third Generation) and Region - Global Forecast to 2029
The biorefinery market is projected to reach USD 314.62 billion by 2029, at a CAGR of 8.2% during the forecast period. Some of the major players in the biorefinery market are Chevron (US), ADM (US), Valero (US), Neste (Finland), and TotalEnergies (France) among others. The major strategies adopted by these players include new product launches, acquisitions, contracts, agreements, partnerships, joint ventures, collaborations, investments, and expansions.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
HPC Data Management Market in Life Sciences By Products & Services (Data Analysis, Cloud Computing), Applications (NGS, Microscopy, Chromatography), End User (Pharmaceutical & Biotechnology, Hospitals) - Global Forecast to 2024
The HPC Data Management Market in life sciences is projected to reach USD 41.1 billion by 2024, at a CAGR of 17.1%. The growth of this market is majorly driven by the growing demand for data storage and management solutions due to extensive amount of data generated through large number of research activities. However, the high cost of implementation and regulatory hurdles are major factors restraining the growth of this market.Dell Technologies Inc. (US), Advanced Micro Devices, Inc. (US), Cray, Inc. (US), Cisco Systems, Inc. (US), IBM Corporation (US), Intel Corporation (US), Lenovo Group Limited (China), Hewlett Packard Enterprise Company (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2023
The global microarray analysis market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.6%. The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays. Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies) & Region- Global Forecast to 2030
The global healthcare data monetization market, valued at US$0.50 billion in 2024, stood at US$0.58 billion in 2025 and is projected to advance at a resilient CAGR of 14.9% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. The growth in this sector is driven by the increasing commercial value of real-time patient data, a growing emphasis on data-driven decision-making in life sciences, and the rise of data-as-a-service (DaaS) business models within healthcare.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
